Kynam Capital Management, LP Q1 2024 Filing

Filed May 15, 2024

Portfolio Value

$955.5B

Holdings

23

Report Date

Q1 2024

Filing Type

13F-HR

All Holdings (23 positions)

#StockSharesValue% PortfolioType
1
NTRANATERA INC
2,000,000$182K0.00%
2
SNDXSYNDAX PHARMACEUTICALS INC
5,660,000$134K0.00%
3
TCE2CELLDEX THERAPEUTICS INC NEW
2,900,000$121K0.00%
4
VERAVERA THERAPEUTICS INC
1,526,787$65K0.00%
5
COGTCOGENT BIOSCIENCES INC
8,500,000$57K0.00%
6
DVAXDYNAVAX TECHNOLOGIES CORP
4,239,780$52K0.00%
7
PCVXVAXCYTE INC
745,000$50K0.00%
8
VRTXVERTEX PHARMACEUTICALS INC
100,000$41K0.00%Put
9
LQDALIQUIDIA CORPORATION
2,248,324$33K0.00%
10
BCRXBIOCRYST PHARMACEUTICALS INC
6,527,491$33K0.00%
11
PTGXPROTAGONIST THERAPEUTICS INC
1,144,242$33K0.00%
12
TSVT*2SEVENTY BIO INC
5,953,825$31K0.00%
13
WVEWAVE LIFE SCIENCES LTD
3,932,082$24K0.00%
14
TVTXTRAVERE THERAPEUTICS INC
2,000,000$15K0.00%
15
HTDCORCEPT THERAPEUTICS INC
585,900$14K0.00%Put
16
IRWDIRONWOOD PHARMACEUTICALS INC
1,625,000$14K0.00%
17
STROSUTRO BIOPHARMA INC
2,001,727$11K0.00%
18
AMRNAMARIN CORP PLC
12,022,957$10K0.00%
19
TYRATYRA BIOSCIENCES INC
515,190$8K0.00%
20
BNRBURNING ROCK BIOTECH LTD
9,640,914$7K0.00%
21
CRBUCARIBOU BIOSCIENCES INC
1,068,527$5K0.00%
22
SLRNACELYRIN INC
396,379$2K0.00%
23
VRDNVIRIDIAN THERAPEUTICS INC
133,877$2K0.00%